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Scientific comment
Tools to implement and improve blood donor hemovigilance 
in Brazil
Cesar de Almeida Neto*
Fundação Pró-Sangue – Hemocentro de São Paulo, São Paulo, SP, Brazil
Hemovigilance deals with the safety of the blood transfusion 
chain and can be summarized in one phrase “safety from vein 
to vein”.1 The first hemovigilance system was established in 
1993 in Japan. In 1994, as a consequence of the HIV scandal, 
France launched a national hemovigilance system and was 
followed by other European countries, such as the United 
Kingdom with the Serious Hazards of Transfusion (SHOT) 
initiative in 1996.1 The French Hemovigilance Network and 
SHOT became a model for other hemovigilance systems 
worldwide. In 2002, The Brazilian Hemovigilance Network 
developed a pilot project to encourage the notification of 
transfusion reactions. At first, this program was only available 
to hospitals belonging to the Sentinel Network. In 2006, the 
possibility to notify a transfusion reaction was expanded 
to all health services with the implementation of a web 
based platform called Notivisa.2 Currently, the Brazilian 
Hemovigilance Network, in line with other international 
systems, is evolving to cover the whole transfusion chain, 
from the collection of blood and its components to the follow-
up of recipients. The expansion of hemovigilance is justified 
as the occurrence of adverse events or noncompliance in the 
blood chain may impact on product quality and on the safety 
of the donor or recipient, and jeopardize the national blood 
transfusion system.
Donor vigilance, a process designed to improve the safety 
of blood donation and the satisfaction of blood donors,3 
is a subsection of hemovigilance that is gaining more and 
more importance in recent years. Blood donors´ safety and 
satisfaction are the cornerstones to construct a model of trust 
between blood centers and the general community. Donor 
vigilance can be applied not only to whole blood donations, 
but also to platelet apheresis, granulocytes, lymphocytes 
and peripheral hematopoietic stem cell donations. It is 
well-known that donors who experience major reactions 
delay longer to return for further donations or do not return 
than those with minor or no reactions.4 Additionally, media 
messages that combine safety of the donation process along 
with who benefits from the donation are considered the 
most effective motivators to donate blood and components.5 
Today, Brazil collects 3.6 million blood units annually which 
corresponds to donations by 1.9% of its population.6 The 
goal of the Brazilian Ministry of Health is to attain 3% of the 
population donating blood regularly to maintain a sufficient 
blood supply. Consequently, measures to record and prevent 
donation reactions must be warranted by national, regional 
and local policies.
The International Society of Blood Transfusion (ISBT) 
provided a Standard for Surveillance of Complications Related 
to Blood Donation in 2008.7 Blood donor complications were 
classified according to type of symptoms (local vs. generalized 
vs. related to apheresis), grading of severity (severe vs. non-
severe), grading of causality (definitive, probable, possible, 
unlikely and excluded) and temporal relation (immediate vs. 
delayed). One of the most challenging barriers to be crossed 
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to get an effective surveillance network is standardizing 
definitions of reportable events in the transfusion chain. 
Although the ISBT has provided a robust reference for donors 
vigilance, that has already been translated to the Portuguese 
spoken in Portugal, cultural and language differences can 
hinder the broad application of this guideline in Brazil.
The prevalence of vasovagal reactions is 2.3% of all whole 
blood donations in Brazil. Young age, low estimated blood 
volume, first-time donor status and female gender are 
major predictors of a vasovagal reaction. Of note, the lack of 
consistent reporting practices based on common definitions 
across Brazilian blood banks may contribute to the different 
rates reported over the country.8 In this issue of the Revista 
Brasileira de Hematologia e Hemoterapia, Braz et al.9 present 
the translation into Brazilian Portuguese and the validation 
of The Blood Donation Reactions Inventory (BDRI). The BDRI 
provides an assessment of subjective ratings of presyncopal 
symptoms that is brief and easily understood by donors, 
and quick to administer and score.10 The BDRI has 11 items 
in its full scale, while short scales have 6 or 4 items. After 
translation, the BDRI scale was applied and validated in 1001 
Brazilian blood donors. The authors concluded that the BDRI 
was a reliable tool for collecting information about systemic 
reactions experienced by blood donors. Moreover, the BDRI 
yields important information about the donor’s experience 
that can be used to predict satisfaction and likelihood of 
repeat donations.10 The BDRI can also help target a population 
of donors in which interventions such as educational 
measures, limited blood volume collection, application of 
muscle tensing exercises, provide distraction and restore 
plasma volume; these are important and likely to reduce the 
unpleasant adverse events of blood donation and increase 
donor retention.
In conclusion, although blood donation is perceived by our 
population as a very safe procedure, standardized instruments 
to standardize registries, to generate reports, to boost bench 
marking among institutions, to prevent unpleasant donation 
reactions, to recruit new and retain repeat donors, are 
welcome. The stronger hemovigilance becomes, the higher 
the credibility and the satisfaction of blood donors; and the 
higher the efficacy of transfusion chain processes will be.
Conflicts of interest
The author declares no conflicts of interest.
R E F E R E N C E S
 1. De Vries RR, Faber JC. Hemovigilance: an effective tool for 
improving transfusion safety. 1st ed. Chichester: John Wiley 
& Sons; 2012.
 2. Agencia Nacional de Vigilância Sanitária. Boletim de 
Hemovigilância nº 5; 2012.
 3. Tomasulo P, Kamel H, Bravo M, James RC, Custer B. 
Interventions to reduce the vasovagal reaction rate in young 
whole blood donors. Transfusion. 2011;51:1511-21.
 4. Custer B, Rios JA, Schlumpf  K, Kakaiya RM, Gottschall JL, 
Wright DJ; NHLBI Retrovirus Epidemiology Donor Study-II 
(REDS-II). Adverse reactions and other factors that impact 
subsequent blood donation visits. Transfusion. 2012;52:118-
26.
 5. Mathew SM, King MR, Glynn SA, Dietz SK, Caswell SL, 
Schreiber GB. Opinions about donating blood among those 
who never gave and those who stopped: a focus group 
assessment. Transfusion. 2007;47:729-35.
 6. Ministério da Saúde. Caderno de informação sangue e 
hemoderivados. 6th Ed. Brasília. Ministério da Saúde;2013.
 7. Standard for Surveillance of Complications Related to Blood 
Donation in 2008. International Society of Blood Transfusion; 
2008. [cited 2014 Feb 15]. Available from: http://www.basg.
gv.at/uploads/media/110207_StandardSurveillanceDOCO.pdf
 8. Gonçalez TT, Sabino EC, Schlumpf KS, Wright DJ, Leao S, 
Sampaio D, et al. ; NHLBI Retrovirus Epidemiology Donor 
Study-II (REDS-II), International Component. Vasovagal 
reactions in whole blood donors at three REDS-II blood 
centers in Brazil. Transfusion. 2012;52:1070-8. 
 9. Braz AC, Almeida RG, Martinez EZ. Translation into 
Portuguese and validation of the Blood Reactions Inventory. 
Rev Bras Hematol Hemoter. 2014;36:139-46.
10. France CR, Ditto B, France JL, Himawan LK. Psychometric 
properties of the Blood Donation Reactions Inventory: 
a subjective measure of presyncopal reactions to blood 
donation. Transfusion. 2008;48:1820-6.
